SCHEMBL9866627

SCHEMBL9866627

CN1c2ccccc2C(C)(C)C12C=Nc1c(ccc3ccncc13)O2

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.78
KDM4E B2RXH2 6/20 0.78
THRB P10828 5/20 0.78
SMN1; SMN2 Q16637 4/20 0.78
ALOX12 P18054 2/20 0.78
L3MBTL1 Q9Y468 2/20 0.78
PKM P14618 2/20 0.78
LMNA P02545 4/20 0.68
GAA P10253 4/20 0.68
ALDH1A1 P00352 3/20 0.68
RECQL P46063 3/20 0.68
TDP1 Q9NUW8 3/20 0.68
HPGD P15428 2/20 0.68
HTT P42858 2/20 0.68
MAPK1 P28482 2/20 0.68
POLB P06746 1/20 0.68
NPSR1 Q6W5P4 3/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29715802 0.92 MAPT (0.78) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL3164187 0.92 MAPT (0.78) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL9868518 0.88 MAPT (0.60) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL13839771 0.88 MAPT (1.00) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL29493002 0.88 MAPT (1.00) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL80364 0.88 MAPT (1.00) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL9866689 0.88 MAPT (0.60) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL9802107 0.87 MAPT (0.59) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL9868283 0.87 MAPT (0.59) MAPTKDM4ETHRBSMN1; SMN2ALOX12
SCHEMBL23800857 0.86 MAPT (0.58) MAPTKDM4ETHRBSMN1; SMN2ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2131486-A None JP disclosed
US-20180179241-A1 BISTABLE COMPLEXES AND DEVICES AND METHODS OF MAKING AND USING THE SAME UVIC INDUSTRY PARTNERSHIPS INC. 2018-06-28 US disclosed
US-20180179241-A1 BISTABLE COMPLEXES AND DEVICES AND METHODS OF MAKING AND USING THE SAME UVIC INDUSTRY PARTNERSHIPS INC. 2018-06-28 US disclosed
WO-2017015765-A1 MAGNETICALLY BISTABLE COMPLEXES AND DEVICES AND METHODS OF MAKING AND USING THE SAME UVIC INDUSTRY PARTNERSHIPS INC. (CA) 2017-02-02 WO disclosed
EP-1754614-B1 Lithographic printing plate precursor and lithographic printing method FUJIFILM CORP (JP) 2009-06-17 EP disclosed
US-7524605-B2 Lithographic printing plate precursor and lithographic printing method FUJIFILM CORPORATION (JP) 2009-04-28 US disclosed
US-7524605-B2 Lithographic printing plate precursor and lithographic printing method FUJIFILM CORPORATION (JP) 2009-04-28 US disclosed
US-20070082291-A1 Lithographic Printing Plate Precursor and Lithographic Printing Method FUJI PHOTO FILM CO., LTD. (JP) 2007-04-12 US disclosed
US-20070082291-A1 Lithographic Printing Plate Precursor and Lithographic Printing Method FUJI PHOTO FILM CO., LTD. (JP) 2007-04-12 US disclosed
EP-1754614-A1 Lithographic printing plate precursor and lithographic printing method Fuji Photo Film Co., Ltd. (JP) 2007-02-21 EP disclosed
US-5017698-A Spirooxazine photochromic compounds KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1991-05-21 US disclosed
JP-H02131486-A PHOTOCHROMIC COMPOUND AND COMPOSITION THEREOF KUREHA CHEM IND CO LTD 1990-05-21 JP disclosed
EP-0350009-A1 Photochromic compound and photochromic composition KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1990-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179241-A1 BISTABLE COMPLEXES AND DEVICES AND METHODS OF MAKING AND USING THE SAME SELE, EPCAM, PIEZO1 MAPT 446/4885KDM4E 101/4885THRB 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.